The quantitative evaluation of antibiotic utilization in community health centers during the COVID-19 pandemic: a cross-sectional multicenter study
The Journal of Infection in Developing Countries · 31.07.2026 · 20 (07) · 954-961
DOI: 10.3855/jidc.22502 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 31.07.2026. Verfasst von Zamharira Muslim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Politeknik Kesehatan Bengkulu, Bengkulu, Indonesia. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Community Health Centers, COVID-19, Drug Utilization. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Uncertainty and rapid changes in treatment guidelines are influencing factors for medication use during the COVID-19 pandemic. Therefore, this study aimed to evaluate antibiotic utilization in Community Health Centers (CHCs) between 2020 and 2021. Methodology: Prescription data from adult outpatient visits (≥ 18 years) receiving prescription services at 35 CHCs in South Jakarta, Malang regency, and Bengkulu city, comprising 796,598 prescriptions, were examined using the ATC/DDD methodology and DU90% analysis. These regions were purposively selected to represent three distinct healthcare archetypes, namely metropolitan (South Jakarta), rural-urban continuum (Malang Regency), and regional cities outside Java (Bengkulu City). Wilcoxon signed-rank and Chi-square tests were used to determine statistical differences between years.
Results
The proportion of adult patient visits receiving a minimum of one antibiotic prescription decreased by 1.56% in 2021 (p < 0.001). Malang Regency recorded the highest rates, decreasing by 2.24% in 2021. Furthermore, the highest DDD values for all antibiotics each year were recorded in South Jakarta, except for Cefadroxil, which peaked in Malang regency. Six antibiotics were constituted in the DU90% segment, with Amoxicillin accounting for over 50% of prescriptions and reaching 425 DDD/1000 patient visits/year in South Jakarta in 2020. In 2021, Azithromycin prescriptions increased significantly by 7.51%, as shown by a p of 0.0161. The average prescribing rate (14.57%) remained below the WHO optimal indicator (< 30%).
Conclusions
Antibiotic use in CHCs declined during the pandemic, but there was a significant increase in Azithromycin prescriptions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Politeknik Kesehatan Bengkulu, Bengkulu, Indonesia.
- Bantur Community Health Centre, Malang Regency Government, Malang, Indonesia.
- Faculty of Pharmacy, Universitas Indonesia, Depok, West Java, Indonesia.
- Department of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
Zitieren
APA
Muslim, Z., Effendi, A. I., Sari, K. C., Hariadini, A. L., & Kusumawardani, L. A. (2026). The quantitative evaluation of antibiotic utilization in community health centers during the COVID-19 pandemic: a cross-sectional multicenter study. The Journal of Infection in Developing Countries, 20(07), 954-961. https://doi.org/10.3855/jidc.22502
Vancouver
Muslim Z, Effendi AI, Sari KC, Hariadini AL, Kusumawardani LA. The quantitative evaluation of antibiotic utilization in community health centers during the COVID-19 pandemic: a cross-sectional multicenter study. The Journal of Infection in Developing Countries. 2026;20(07):954-961. doi:10.3855/jidc.22502
BibTeX
@article{Muslim2026,
author = {Muslim, Zamharira and Effendi, Angga Iw and Sari, Kartika Cdp and Hariadini, Ayuk L and Kusumawardani, Larasati A},
title = {The quantitative evaluation of antibiotic utilization in community health centers during the COVID-19 pandemic: a cross-sectional multicenter study},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
volume = {20},
number = {07},
pages = {954--961},
doi = {10.3855/jidc.22502}
}
EUVIMED